13F HOLDINGS REPORT
Samsara BioCapital, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001744967-25-000004
Total Value
$765.9M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MINERALYS THERAPEUTICS INC | MLYS | 6,263,151 | $237.5M | 31.01% |
| 2 | SCHOLAR ROCK HLDG CORP | SRRK | 5,612,896 | $209.0M | 27.29% |
| 3 | KALARIS THERAPEUTICS INC | KLRS | 11,448,081 | $66.2M | 8.64% |
| 4 | SEPTERNA INC | SEPN | 3,149,128 | $59.2M | 7.73% |
| 5 | NEUROGENE INC | NGNE | 1,717,127 | $29.8M | 3.89% |
| 6 | ALUMIS INC | ALMS | 4,801,370 | $19.2M | 2.50% |
| 7 | UPSTREAM BIO INC | UPB | 962,154 | $18.1M | 2.36% |
| 8 | GOSSAMER BIO INC | GOSS | 6,130,268 | $16.1M | 2.10% |
| 9 | LENZ THERAPEUTICS INC | LENZ | 343,012 | $16.0M | 2.09% |
| 10 | AQUESTIVE THERAPEUTICS INC | AQST | 2,500,000 | $14.0M | 1.82% |
| 11 | PALVELLA THERAPEUTICS INC NE | PVLA | 209,634 | $13.1M | 1.72% |
| 12 | AVADEL PHARMACEUTICALS PLC | G29687103 | 675,504 | $10.3M | 1.35% |
| 13 | VTV THERAPEUTICS INC | VTVT | 374,461 | $8.7M | 1.14% |
| 14 | NKARTA INC | NKTX | 3,768,035 | $7.8M | 1.02% |
| 15 | CONTINEUM THERAPEUTICS INC | CTNM | 571,142 | $6.7M | 0.88% |
| 16 | ARCELLX INC | ACLX | 81,165 | $6.7M | 0.87% |
| 17 | ABIVAX SA | AAVXF | 75,442 | $6.4M | 0.84% |
| 18 | JADE BIOSCIENCES INC | JBIO | 531,163 | $4.6M | 0.60% |
| 19 | AURA BIOSCIENCES INC | AURA | 584,849 | $3.6M | 0.47% |
| 20 | ZYMEWORKS INC | ZYME | 207,901 | $3.6M | 0.46% |
| 21 | SURROZEN INC | SRZNW | 241,400 | $3.1M | 0.41% |
| 22 | RHYTHM PHARMACEUTICALS INC | RYTM | 30,285 | $3.1M | 0.40% |
| 23 | SUTRO BIOPHARMA INC | STRO | 2,196,814 | $1.9M | 0.25% |
| 24 | TERNS PHARMACEUTICALS INC | TERN | 135,573 | $1.0M | 0.13% |
| 25 | BOLT BIOTHERAPEUTICS INC | BOLT | 48,830 | $259,776 | 0.03% |
| 26 | NUVATION BIO INC | NUVB | 133,333 | $26,947 | 0.00% |
| 27 | SURROZEN INC | SRZNW | 99,999 | $1,780 | 0.00% |